The Association of European Cancer Leagues (ECL) is an NGO leading on cancer control actions at the European level since 1980. Represented by members in EU and non-EU countries, cancer leagues are the main resource for the public for cancer control information and services. As the only network exclusively for cancer leagues, ECL provides a unique platform for cancer leagues to share knowledge and experience. Prior to receiving operational grant funding, the running of ECL had been financed mainly by membership fees. The addition of EU co-financing since 2015 has allowed ECL to implement activities more effectively in line with our multi-annual strategy, leading to the progressive increase in activities across all 5 of our strategic goals, providing considerable EU added-value in the process. EU co-funding has enabled ECL to increase our work in cancer prevention, especially the promotion of the European Code Against Cancer (ECAC). This has led to the design of new communication tools to raise awareness amongst the general public; the creation of a youth ambassadors programme to improve dissemination amongst young people; and enhanced networking opportunities for leagues allowing them to share best practice and collaborate more efficiently. In 2017, ECL will continue to disseminate the ECAC, making efforts to measure and assess the impact of these activities. ECL will increase efforts to have explicit references to the ECAC in updated National Cancer Control Plans, and will place greater emphasis on the role of cancer leagues in promoting organised cancer screening programmes. ECL will continue its leading role in tobacco control by supporting the 2017 European Conference on Tobacco or Health (ECToH). ECL shall also launch a new task force on the crucial issue of equal access to medicines. This will complement ECL's ongoing secretariat work on behalf of the MEPs Against Cancer interest group of the European Parliament, and the Patient Support Working Group of ECL.


The overarching goal of the SFP Coalition multiannual work programme between 2018 and 2021 is to prevent cancer and chronic diseases through smoking prevention at EU and national level with a special focus on young people and health in all policies. In the third year of the multi-annual programme, the SFP Coalition will work on:

- The multi-annual campaign for raising tobacco excise duties through national and EU-level policy advocacy
- The multi-annual campaign to raise awareness of and support for tobacco control research
- Developing and implementing an awareness campaign towards policy-makers to recognize the crucial role of tobacco control in the prevention of non-communicable diseases and promotion of sustainable health systems in both national health policy and in development policy
- Encouraging civil dialogue by continuing to build capacity of health organisations to engage in the monitoring the EU’s track and trace system and its 2018 strategy and action plan to fight against illicit trade.
- Developing an evidence-based advocacy campaign for strengthening tobacco advertising, promotion and sponsorship regulations at national and EU level
- Raising awareness and building broad support for tobacco control and FCTC obligations amongst policy makers and the health and research community
- Coordinating European civil society positions and activities at the 9th session of the Conference of the Parties to the FCTC and 2nd Meeting of the Parties to the Illicit Trade Protocol, with a view to supporting global advocacy and actionable decisions for civil society in the EURO region
- Monitoring, exposing and rebutting tobacco industry interference (throughout all policy and advocacy work).

SFP will also continue engaging Coalition members in EU level campaigns and supporting national efforts to improve tobacco control policies by strengthening capacity for effective civil dialogue and tobacco control advocacy at national, European and global levels.


The Association of European Cancer Leagues (ECL) provides a unique platform as the only organisation with the mission of uniting at the European level, national and regional cancer leagues to achieve a cancer-free Europe. In coherence with the FPA 2018-2021, and building upon the outcomes from previous years of the FPA, this proposal focuses on the core activities to be implemented in 2021 in respect of the following strategic objectives:

1) Ensuring cancer control remains high on the political agenda;
2) Promoting the European Code Against Cancer (ECAC) as the essential tool for cancer prevention;
3) Supporting the implementation of the Council Recommendation on Cancer Screening (2003); and
4) Uniting leagues to advocate for equal access to treatment, support, and rehabilitation for cancer patients;
5) Advocating for the European Guide for quality improvement in cancer control to be mainstreamed in national cancer plans.
These objectives will be achieved by several actions, including:

- Implementing the MEPs against Cancer (MAC) 2019 elections manifesto and supporting with a toolkit to commemorate World Cancer Day;
- Publishing a communication guideline for cancer leagues to promote the European Week against cancer (EWAC);
- Developing the viewpoint of cancer leagues on the future of the European Code against Cancer (ECAC) based on the findings of the ECAC evaluation;
- Create a special tutorial on the background and application of the ECAC for young advocates in the ECL Youth Ambassadors programme;
- Supporting the roadmap towards a 3rd implementation report on cancer screening in the EU;
- Releasing the updated edition of the Patient Support Working Group Rehabilitation Atlas;
- Continuation of the advocacy work of the ECL Access to Medicines Task Force implementing the 2018 'Let's Talk Access'
White Paper on Equal Access to Medicines.


The general objective of the Joint Action – Innovative Partnership for Action Against Cancer (iPAAC JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The development of innovative approaches to cancer control will be supplemented by a Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support Member States in implementation of iPAAC and CANCON recommendations. The Roadmap will act as the central pillar of the JA, integrating the diverse topic areas, providing synergies between the topics, ensuring consideration of transversal issues for all topics and acting as the central comprehensive deliverable, integrating all the JA outputs. A variety of methods will be used to fulfil the general and specific objectives including pilot studies, working groups, expert panels, literature review and surveys. A governmental board will be in place to ensure that implementation and sustainability in national contexts are duly considered for each topic area. The proposal for the iPAAC JA proposes actions to address objective 1 of the 2017 annual work programme, that is promoting health, preventing diseases and fostering supportive environments for healthy lifestyles taking into account the ‘health in all policies’ principle. The work to be developed by the iPAAC JA is complementary to the outcomes of the EPAAC and CANCON Joint Actions, funded by the Second and Third Health Programmes and will build on their outputs, using the stakeholder networks as an optimal base for the development of innovative cancer control actions.


The Smoke Free Partnership (SFP) is the only Coalition of national, pan-European and international NGOs working exclusively on EU policy analysis and advocacy linked to the implementation of the WHO Framework Convention on Tobacco Control (FCTC). Since its creation in 2005, SFP has led many successful campaigns to advance important EU smoking prevention policy areas, most notably European smoke-free policies and the Tobacco Products Directive, but also the EU Tobacco Tax Directive and policies against illicit tobacco trade. SFP has been recognised for its tobacco control work by the World Health Organisation with the World No Tobacco Day Award in 2011. SFP was also a recipient of the American Cancer Society’s 2015 Luther L. Terry Award for outstanding global achievement and exemplary leadership in Tobacco Control.
This application demonstrates how our strategic objectives directly respond to the first three specific priority areas of the 2017 Call for Proposals for Operating Grants. In particular, SFP and its Coalition Partners will assist the EU institutions and national governments with information and evidence-based intelligence and advice for the development of smoking prevention policies and the promotion of healthy lifestyles to prevent cancer and chronic diseases at EU and national level with a special focus on young people, reducing health inequalities, and promoting health in all policies. SFP will contributing to civil dialogue processes to increase public authorities’ commitment in this area by spearheading successful campaigns and building advocacy capacity among civil society organisations. This application also describes how we will contribute to the objectives of the European Solidarity Corps.
Based on our previous track record of producing results, this application also demonstrates how SFP and its Coalition partners will continue to contribute to the overarching and specific objectives of the Third Health Programme (2014-2020).
